Revenue
2019
2020
2021
2022
2023
2024
2025
MAXCYTE, INC. (MXCT)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $21.0M | $22.2M | $19.5M | $28.7M | $21.6M | $15.5M | $13.3M |
| Gross profit | $26.8M | $31.5M | $36.5M | $39.2M | $30.2M | $23.4M | $19.1M |
| Research & development | $20.8M | $22.2M | $23.8M | $19.5M | $15.4M | $17.7M | $17.6M |
| Operating expenses | $78.7M | $82.7M | $84.8M | $66.5M | $48.4M | $34.5M | $31.5M |
| Operating income | −$51.9M | −$51.2M | −$48.3M | −$27.4M | −$18.2M | −$11.1M | −$12.4M |
| EBITDAderived | −$47.6M | −$46.9M | −$44.1M | −$24.7M | −$16.8M | −$10.0M | −$11.8M |
| Net income | −$44.6M | −$41.1M | −$37.9M | −$23.6M | −$19.1M | −$11.8M | −$12.9M |
| Basic EPSper diluted share | -$0.42 | -$0.39 | -$0.37 | -$0.23 | -$0.21 | -$0.17 | -$0.23 |
| Diluted EPSper diluted share | -$0.42 | -$0.39 | -$0.37 | -$0.23 | -$0.21 | -$0.17 | -$0.23 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 17, 2026Form 4 | Swirsky Douglas JCHIEF FINANCIAL OFFICER | SellCommon Stock | 10.1K | $0.82 | $8.3K | 151.7K |
| Aug 13, 2025Form 4 | Swirsky Douglas JCHIEF FINANCIAL OFFICER | BuyCommon Stock | 50.0K | $1.29 | $64.5K | 161.8K |
| Aug 13, 2025Form 4 | Masoud MaherPresident and CEO | BuyCommon Stock | 75.0K | $1.37 | $102.8K | 175.0K |
| Aug 13, 2025Form 4 | Erck Stanley CDirector | BuyCommon Stock | 100.0K | $1.37 | $137.0K | 398.3K |
| Aug 13, 2025Form 4 | DOUGLAS RICHARDDirector | BuyCommon Stock | 80.0K | $1.39 | $111.2K | 230.6K |